|
||
| |||||||
|
Nonlinear Dynamics Release New Version of Progenesis 24
June 2004 (Newcastle upon Tyne, UK) Nonlinear
Dynamics, a leading provider of bioinformatics solutions, announced the new
release of its flagship product Progenesis which now incorporates Cross Stain
Analysis Technology. Already the leading product in advanced 2D Proteomic image
analysis, Progenesis looks set to remain at the forefront of 2DE software
technology. Following
its initial release in May 2001, Progenesis has established itself as the most
sophisticated solution for enhanced 2D gel analysis. Global sales have risen
vigorously over the last three years and this rate looks set to continue over
the coming months. The evolving demands of proteomics research have seen
numerous high
profile institutions invest in the Progenesis platform from across a range of
research sectors. Many major pharmaceutical organisations have invested in
Progenesis, including AstraZeneca, GlaxoSmithKline and Pfizer while
biotechnology companies such as Genzyme and VTT Medical Biotechnology have also
adopted the product. Similarly, the growing profile and demand of the proteomics
research market has led to many core and commercial
service
laboratories adopting the Progenesis platform, including Charles River Proteomic
Services, Proteomic Research Services, University of Texas Medical Branch, and
the US Department of Agriculture (USDA). Dr
James Jersey, President of Charles River Proteomic
Services
(Worcester, MA) said, “In our gel-based service offerings, we are dedicated to
providing our clients with the highest quality data possible with the minimum
turnaround time. Charles
River Proteomic Services has the
ability to rapidly and accurately process many complex samples in a highly
automated fashion and provide objective, statistically based measures of
significance through the application of a variety of statistical tools. As
a result, the software
must provide functionality enabling efficient review, visualization and mining
of the large data sets.
The Progenesis software meets
this objective and provides
an
important competitive edge in the proteomic research market.” The
Progenesis software incorporates the latest technology to conduct objective 2DE
research using statistically driven proteomics. Progenesis delivers a high level
of automation providing advanced quality of data analysis, data-mining and
support of lab based research. The latest enhancements to the product include
new Cross Stain Analysis technology, allowing users to analyse multiplexed 2D
gels containing an internal standard. Other innovative features include the
unique Intelligent Noise Correction Algorithm (INCA) which controls the effect
of image noise to drive accurate analysis. This feature, coupled with Data
Quality Control (Data QC), provides the user with a statistical measure of
whether changes in spots are significant compared to the overall quality of the
gel. John
Spreadbury, Group Sales and Marketing Director at Nonlinear Dynamics and CEO of
Nonlinear Inc, said, “Proteomics research demands consistency, accuracy and
reliability from analysis software. As a product, Progenesis delivers on all
these counts. The new features and
the integration of CSA technology in the updated Progenesis software builds on
an already outstanding product and allows our users to remain at the forefront
2D analysis innovation.” -
ENDS - About
Nonlinear Dynamics Ltd
Established
in 1989, Nonlinear Dynamics is a leading worldwide provider of bioinformatics
solutions to the life science industry. The Company’s innovative product
portfolio comprises high-quality analysis and data mining tools for 1D and 2D
electrophoresis gels and microarrays, the core technologies of genomics and
proteomics. Nonlinear sells and supports its products through its UK
headquarters, its USA office, and its global network of partners and OEM
resellers. Contact:
James Sykes, Group Marketing Manager Tel:
+44 191 230 2121; james.sykes@nonlinear.com;
www.nonlinear.com
|
|
| ||||||||